Pfizer Receives FDA Approval For Cheaper Version Of Johnson & Johnson's Top Drug Remicade
April 06, 2016 at 10:45 AM EDT
Pfizer Inc. (NYSE: PFE) announced after Tuesday's market close that the U.S. Food and Drug Administration approved INFLECTRA, the ...